90 related articles for article (PubMed ID: 22052167)
21. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
Shimamoto T; Ohyashiki JH; Ohyashiki K
Leuk Res; 2005 Jun; 29(6):653-9. PubMed ID: 15863205
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Am J Hematol; 2005 Dec; 80(4):282-7. PubMed ID: 16315255
[TBL] [Abstract][Full Text] [Related]
23. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z
BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.
Wagner M; Schmelz K; Dörken B; Tamm I
Leuk Res; 2008 Jul; 32(7):1054-60. PubMed ID: 18206228
[TBL] [Abstract][Full Text] [Related]
25. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
Lapillonne H; Renneville A; Auvrignon A; Flamant C; Blaise A; Perot C; Lai JL; Ballerini P; Mazingue F; Fasola S; Dehée A; Bellman F; Adam M; Labopin M; Douay L; Leverger G; Preudhomme C; Landman-Parker J
J Clin Oncol; 2006 Apr; 24(10):1507-15. PubMed ID: 16575000
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.
Rethmeier A; Aggerholm A; Olesen LH; Juhl-Christensen C; Nyvold CG; Guldberg P; Hokland P
Br J Haematol; 2006 May; 133(3):276-83. PubMed ID: 16643429
[TBL] [Abstract][Full Text] [Related]
28. Associations between TFPI-2 methylation and poor prognosis in glioblastomas.
Vaitkienė P; Skiriutė D; Skauminas K; Tamašauskas A
Medicina (Kaunas); 2012; 48(7):345-9. PubMed ID: 23032906
[TBL] [Abstract][Full Text] [Related]
29. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.
Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T
Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720
[TBL] [Abstract][Full Text] [Related]
30. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
Jost E; do O N; Wilop S; Herman JG; Osieka R; Galm O
Leuk Res; 2009 Mar; 33(3):443-9. PubMed ID: 18757096
[TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia.
Ekmekci CG; Gutiérrez MI; Siraj AK; Ozbek U; Bhatia K
Am J Hematol; 2004 Nov; 77(3):233-40. PubMed ID: 15495254
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
33. [Methylation and expression of glioma pathogenesis-related protein 1 gene in acute myeloid leukemia].
Liang T; Tan T; Xiao Y; Yi H; Li C; Peng F; Chen Z; Xiao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 May; 34(5):388-94. PubMed ID: 19483285
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia.
Xu Z; Wang M; Wang L; Wang Y; Zhao X; Rao Q; Wang J
Leuk Res; 2009 Jul; 33(7):891-7. PubMed ID: 19250671
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
Ribarska T; Ingenwerth M; Goering W; Engers R; Schulz WA
Cancer Genomics Proteomics; 2010; 7(2):51-60. PubMed ID: 20335518
[TBL] [Abstract][Full Text] [Related]
37. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
38. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques.
Zawadzki C; Chatelain N; Delestre M; Susen S; Quesnel B; Juthier F; Jeanpierre E; Azzaoui R; Corseaux D; Breyne J; Torpier G; Staels B; Van Belle E; Jude B
Atherosclerosis; 2009 Jun; 204(2):e4-14. PubMed ID: 19081094
[TBL] [Abstract][Full Text] [Related]
39. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
